Treace to Present at Stifel 2023 Healthcare Conference
30 oct. 2023 07h00 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Report Third Quarter 2023 Financial Results
16 oct. 2023 07h00 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023
20 sept. 2023 07h00 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent
14 sept. 2023 16h05 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures
11 sept. 2023 16h05 HE
|
Treace Medical Concepts, Inc.
Further Expands Market Opportunity to Include Hammertoe Correction Company Receives 510(k) Clearance for Second-Generation SpeedPlate™ Implant Fixation Platform Ahead of Full Market Launch in Fourth...
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
22 août 2023 16h05 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing
21 août 2023 07h00 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
08 août 2023 16h05 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Participation in the UBS Medtech, Tools and Genomics Summit 2023
24 juil. 2023 16h05 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., July 24, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
18 juil. 2023 16h15 HE
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...